InnoCare Pharma (09969) issues 8 million restricted shares.
Nuocheng Jianhua (09969) announced that after the close of trading today and the end of the shareholders' annual meeting, the company has made its first grant under the 2026 Renminbi stock incentive plan, granting 8 million restricted shares to 100 incentive recipients, accounting for approximately 0.45% of the total number of issued shares of the company as of the date of this announcement.
InnoCare Pharma (09969) announced that after the market closed today and the end of the shareholders' annual meeting, the company has granted the first award under the 2026 Renminbi Stock Incentive Plan, awarding 8 million restricted shares to 100 incentive recipients, accounting for approximately 0.45% of the total number of shares issued by the company on the date of this announcement.
Related Articles
A senior executive of Nanjing Insititute of Surveying, Mapping & Geotechnical Investigation Co. Ltd (stock code 300826.SZ) plans to reduce their holdings by no more than 60,000 shares.
JD INDUSTRIALS (07618) repurchased approximately 108,400 shares for approximately HK$1.4544 million on June 16th.
NAYUKI (02150) spent 373,900 Hong Kong dollars to repurchase 486,000 shares on June 16th.
A senior executive of Nanjing Insititute of Surveying, Mapping & Geotechnical Investigation Co. Ltd (stock code 300826.SZ) plans to reduce their holdings by no more than 60,000 shares.
JD INDUSTRIALS (07618) repurchased approximately 108,400 shares for approximately HK$1.4544 million on June 16th.
NAYUKI (02150) spent 373,900 Hong Kong dollars to repurchase 486,000 shares on June 16th.
RECOMMEND
